How accurate are manufacturers’ recommendations in determining ineligibility for transfemoral transcatheter aortic valve implantation?

Autor: Beytullah Çakal, Sinem Çakal, Oguz Karaca, Filiz Kizilirmak Yilmaz, Haci Murat Gunes, Arzu Yıldırım, Yeliz Guler, Özgür Ulaş Ozcan, Bilal Boztosun
Jazyk: English<br />Portuguese
Rok vydání: 2023
Předmět:
Zdroj: Revista Portuguesa de Cardiologia, Vol 42, Iss 1, Pp 31-38 (2023)
Druh dokumentu: article
ISSN: 0870-2551
DOI: 10.1016/j.repc.2021.09.019
Popis: Introduction: Up to one-third of patients indicated for transcatheter aortic valve implantation (TAVI) may be unsuitable for transfemoral TAVI (TF-TAVI) according to manufacturers’ recommendations and numerous professional societies. Objective: This study aimed to investigate the predictive value of manufacturers’ guidelines for major vascular access site complications using the Perclose ProGlide device. Methods: Among 208 patients undergoing TF-TAVI, 144 patients (69.2%) were deemed eligible for TF-TAVI according to the manufacturer's instructions. A minimal lumen diameter (MLD) of the femoral artery below the manufacturer's specified limits and/or the presence of circumferential calcification were the reasons for ineligibility. Calcium score (CS), sheath-to-femoral artery ratio (SFAR) and MLD were estimated from computed tomography imaging. Vascular complications (VCs) (defined according to VARC-2 criteria) were retrospectively compared. Results: Patients in the ineligible group had higher SFAR (1.13±0.15 vs. 0.88±0.107, p
Databáze: Directory of Open Access Journals